Single and Multiple Ascending Doses of AZD1981 in Japan (JSAD/JMAD)

AstraZeneca

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: AZD1981; Drug: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT00698282

D9831C00005

Details and patient eligibility

About

The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects

Enrollment: 47 patients

Sex: Male

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy Japanese and Caucasian males

Exclusion criteria

• Other clinically relevant disease or disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Quadruple Blind

---

47 participants in 3 patient groups, including a placebo group

1

Experimental group

Treatment:

Drug: AZD1981

Drug: AZD1981

2

Experimental group

Treatment:

Drug: AZD1981

Drug: AZD1981

3

Placebo Comparator group

Treatment:

Drug: Placebo